tiprankstipranks
Starpharma Releases Governance Documents
Company Announcements

Starpharma Releases Governance Documents

Starpharma Holdings Limited (AU:SPL) has released an update.

Don't Miss Our Christmas Offers:

Starpharma Holdings Limited, an Australian biotechnology firm, has released its Appendix 4G and Corporate Governance Statement, complying with the ASX Listing Rules. The company specializes in dendrimer technology to improve health outcomes in significant illnesses, including cancer, and boasts a portfolio of clinical-stage assets and OTC products. Details of the corporate governance disclosures can be found on the company’s website.

For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskStarpharma CEO Receives Major Performance Rights Issuance
TipRanks Australian Auto-Generated NewsdeskStarpharma Issues Unquoted Securities to Boost Employee Incentives
TipRanks Australian Auto-Generated NewsdeskStarpharma Holdings Reports Successful AGM Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App